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Although echinomycin s reported to intercalate and to bind to DNA at CG dinucleotides, the effects of 
the drug on DNA methylation i  vitro and in vivo are much less apparent than are the effects on DNA 
synthesis and cell growth. 
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1. INTRODUCTION 
Echinomycin is a member of the quinoxaline 
group of antibiotics which has been shown to bind 
tightly to DNA, especially in GC-rich regions [l]. 
Detailed kinetic and DNase footprinting studies 
suggest hat the antibiotic acts as a bifunctional in- 
tercalating agent showing high specificity for the 
symmetrical CG dinucleotide [2,3]. The intercala- 
tion reaction involves an altered helix conforma- 
tion and is inhibited by monovalent cation 
concentrations which interfere with the breathing 
of native DNA [2,4,5]. No interaction is observed 
with single-stranded DNA [5]. 
The above characteristics are reminiscent of the 
conditions required for interaction of eukaryotic 
DNA methylase with native DNA [6,7] and we 
therefore have investigated whether the reported 
effects of echinomycin on the growth of tumours 
might be related to an inhibition of DNA methyla- 
tion by the drug. 
2. MATERIALS AND METHODS 
DNA methylase purified from Krebs II ascites 
tumour cells [8] was incubated with a limiting 
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amount of native M. Iuteus DNA in a low salt buf- 
fer. The DNA was preincubated with echinomycin 
in the methylase assay buffer containing 35% 
methanol and the assays were performed in the 
presence of 20% methanol. The echinomycin was 
a generous gift of Drs Peter and Scheibi of Ciba- 
Geigy AG, Basel. 
DNA synthesis and methylation in vivo were 
assayed by incubating mouse L929 cells with 
[6-3H]uridine (10 &i/ml) for 6 h. The DNA was 
then purified and the bases separated on a column 
of Aminex A6 (BioRad) [9]. The radioactivity in 
DNA cytosine and methylcytosine is a measure of 
the rate of DNA synthesis (similar results were ob- 
tained following incubation with tritiated 
thymidine) and the level of DNA methylation is ex- 
pressed as cpm in methylcytosin x lOO/cpm in 
cytosine and methylcytosine. 
3. RESULTS 
Low et al. [2] report that protection of DNA 
from DNase I action was obtained with 
echinomycin concentrations of between 2 PM and 
8 PM and DNA becomes saturated with 
echinomycin when there is one drug molecule for 
every five base pairs of DNA [5] though this must 
be dependent on DNA base composition. 
We, therefore, preincubated 1 pg Micrococcus 
luteus or other DNA with the drug at various con- 
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centrations up to 3.5 PM which would supply 1.8 
echinomycin molecules for every CG dinucleotide 
pair, i.e. twice the number required to saturate the 
DNA. The DNA was then used as a substrate in a 
DNA methylase assay. At DNA/drug ratios of 
20-40 bp/drug there is a 35070 stimulation of 
methylase activity perhaps resulting from a loosen- 
ing of the tight double helical structure of the 
DNA, but as this ratio falls to 6 the enzyme reac- 
tion is inhibited to about 40% of the maximum 
value (fig. 1). 
Could such an inhibition of DNA methylation 
account for the reported effect of the drug on cell 
growth? Fig.2 shows the effect of different drug 
concentrations on the growth of mouse L929 cells 
and on DNA synthesis in these cells. 50% inhibi- 
tion is achieved with lo-25 nM echinomycin, i.e. 
60 pmol per dish. The control dishes contained lo6 
cells, i.e. about 1Opg DNA which, because of the 
low GC content and the CG dinucleotide deficien- 
cy [lo] would contain about 120 pmol CG 
bp/echinomycln 
44 22 11 6.7 
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Fig.1. Effect of echinomycin on DNA methylase 
activity. 1 pg native M. luteus DNA was incubated with 
echinomycin at 37°C for 20 min in 40~1 and then used 
as a substrate for a partially purified DNA methylase. 
The concentration of echinomycin is that present in the 
assay (volume 70,~l) in which the DNA is limiting. 
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Fig.2. Effect of echinomycin on DNA synthesis and 
methylation in vivo and on cell growth. Mouse L929 
cells were cultured in the presence of the indicated 
concentrations of echinomycin. DNA synthesis and 
methylation were assayed as described in section 2 after 
incubation with [6-3H]uridine from 16-22 h after drug 
addition. The level of DNA methylation (0) is 
expressed as cpm in methylcytosine x lOO/cpm in 
cytosine + methylcytosine. The rate of DNA synthesis 
(0) is the cpm incorporated into cytosine plus 
methylcytosine x 10m3. (Similar results for inhibition of 
DNA synthesis were obtained by following incubation 
with [‘HJthymidine.) Cell number was measured 48 h 
after drug addition and the results are expressed as fold 
increase in cell number (A). 
dinucleotide pairs. Thus 50% inhibition of DNA 
synthesis and cell growth is obtained at a CG 
pair/drug ratio of about 2 compared to 0.8 which 
is required to inhibit in vitro DNA methylation to 
a similar extent. The drug was always administered 
in a constant volume of 35% methanol (56 /rl per 
ml culture medium) and this by itself inhibits DNA 
synthesis by 50%. All controls were therefore 
treated with methanol. Investigation of the effect 
of echinomycin on in vivo methylation of DNA 
shows that the DNA made 16-22 h after drug ad- 
ministration is onlv slightly less methylated than 
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control (fig.2). Thus while 280 nM echinomycin 
inhibits incorporation of [6-3H]uridine into DNA- 
cytosine + methylcytosine by 99%, the DNA 
which is produced has 3.0% of its cytosine residues 
methylated compared with 3.6% for control DNA. 
4. DISCUSSION 
In an assay for DNA methylase activity in which 
the rate limiting DNA was preincubated with 
echinomycin, 50% inhibition of maximal activity 
was obtained at a drug concentration of 2.5 pM. 
This represents a base pair per drug ratio of 8.3 
which, because of the high CC dinucleotide con- 
tent of the M. luteus DNA used represents 8.3 base 
pairs or about 0.8 CC pairs per drug molecule. In 
this de novo methylase reaction both cytosines in 
the CC dinucleotide pair are available for methyla- 
tion yet when these are fully complexed with 
echinomycin only 50% inhibition of methylation 
occurs. 
In vivo 12 nM echinomycin causes 50% inhibi- 
tion of DNA synthesis and growth of cultured 
mouse L929 cells. This represents 250 base pairs 
per drug molecule but because of the CC 
dinucleotide deficiency of mouse DNA, this 
represents 2 CC pairs per drug molecule. Thus the 
two DNA strands may be cross linked only every 
250 bsae pairs but every other CC dinucleotide pair 
is associated with a molecule of echinomycin. 
Despite this the effect on in vivo methylation is 
very slight. In this case the methylation occurring 
in mouse L929 cells is maintenance methylation 
but it shows even less sensitivity than the de novo 
methylase activity assayed in vitro. 
It is possible that the DNA methylation observed 
in drug-treated cells is occurring in a small fraction 
of cells not affected by the drug. However, 
autoradiography of [3H]thymidine-labelled cells 
shows that the percentage of cells making DNA 
only falls from 32.1 * 4.7% in the absence of 
echinomycin to 17.2 f 3.0% in the presence of 
70 nM echinomycin. In the control, 62% of the 
labelled cells had over 100 grains per cell whereas 
this figure was only 22% in cells treated with 
70 nM echinomycin. No labelled cells were 
detected in samples treated with 280 nM 
echinomycin. This shows that no resistant cells are 
present and that the rate of DNA synthesis is 
reduced to a similar extent in all cells. 
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The failure of echinomycin to inhibit DNA 
methylation while strongly inhibiting DNA and 
RNA synthesis may imply that methylation does 
not involve the transient separation of the base 
pairs. The bifunctional intercalating agent has two 
quinoxaline rings held rigidly parallel and 1 nm 
apart by the perpendicular peptide disc [l]. When 
the quinoxaline rings intercalate into native DNA 
they sandwich 2 base pairs and extend the DNA 
chain by about 0.7 nm per drug molecule bound. 
The peptide cross bridge gives specificity by inter- 
calating with base pair substituents in the narrow 
groove of the helix, e.g. the a-amino group of 
guanine [l]. In this respect he drug may not block 
access to the major groove and may not seriously 
affect the conformation of a sandwiched CC 
dinucleotide pair. 
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